Search

everythinglearnresearchcommunity

for

Search:↓

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

The combination treatment showed a higher response rate but no significant survival benefits.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Promising cancer treatments were found, but the manufacturer closed.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

The combination of encorafenib and binimetinib caused few skin issues.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Tofacitinib might be used to treat hair loss.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Axitinib treatment turned a man's grey hair back to black.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

c-Kit is important for heart regeneration and cancer development.